News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
With the recent introduction of its Reveal platform, the company behind the 1000 Genomes Project browser wants to unlock the potential of the UK Biobank dataset.
Finnish medical evidence provider Medaffcon will tap BC Platforms' global biobank analysis platform to generate medical evidence for researchers.
The transaction follows 10x Genomics' acquisition of Stanford University spinout Epinomics and technology development partnerships with BioLegend and Immudex.
With genealogical data for 3.4 million individuals from Quebec, investigators traced a rare heart and digestive disease back to two 17th century founder families.
The partners will develop technology to predict the outcome of an NK-cell-based immunotherapy in patients with incurable locally advanced or metastatic solid tumors.
